BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7530137)

  • 21. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer.
    Irie A; Yamauchi A; Kontani K; Kihara M; Liu D; Shirato Y; Seki M; Nishi N; Nakamura T; Yokomise H; Hirashima M
    Clin Cancer Res; 2005 Apr; 11(8):2962-8. PubMed ID: 15837748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenascin-C induction in Whitlock-Witte culture: a relevant role of the thiol moiety in lymphoid-lineage differentiation.
    Sakai T; Ohta M; Kawakatsu H; Furukawa Y; Saito M
    Exp Cell Res; 1995 Apr; 217(2):395-403. PubMed ID: 7535236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opposing roles of netrin-1 and the dependence receptor DCC in cancer cell invasion, tumor growth and metastasis.
    Rodrigues S; De Wever O; Bruyneel E; Rooney RJ; Gespach C
    Oncogene; 2007 Aug; 26(38):5615-25. PubMed ID: 17334389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis.
    Kuniyasu H; Ohmori H; Sasaki T; Sasahira T; Yoshida K; Kitadai Y; Fidler IJ
    Clin Cancer Res; 2003 Oct; 9(13):4802-10. PubMed ID: 14581351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.
    Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA
    Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tenascin in breast carcinoma: distribution and significance].
    Mangili F; Sassi I; Resta B; Paganelli G; Cantaboni A
    Pathologica; 1992; 84(1094):79-81. PubMed ID: 1284447
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional role of cytotactin/tenascin in morphogenesis: a modest proposal.
    Crossin KL
    Perspect Dev Neurobiol; 1994; 2(1):21-32. PubMed ID: 7530140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.
    Fichtner I; Dehmel A; Naundorf H; Finke LH
    Anticancer Res; 1997; 17(5A):3633-45. PubMed ID: 9413216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma.
    Linder S; Castaños-Velez E; von Rosen A; Biberfeld P
    Hepatogastroenterology; 2001; 48(41):1321-7. PubMed ID: 11677955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
    Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
    Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenascin protein and mRNA in the avian visual system: distribution and potential contribution to retinotectal development.
    Perez RG; Halfter W
    Perspect Dev Neurobiol; 1994; 2(1):75-87. PubMed ID: 7530146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Matrix-degrading metalloproteinases in tumor progression.
    Matrisian LM; Wright J; Newell K; Witty JP
    Princess Takamatsu Symp; 1994; 24():152-61. PubMed ID: 8983072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenascin-contactin/F11 interactions: a clue for a developmental role?
    Vaughan L; Weber P; D'Alessandri L; Zisch AH; Winterhalter KH
    Perspect Dev Neurobiol; 1994; 2(1):43-52. PubMed ID: 7530143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
    Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
    Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The perplexing multifunctionality of janusin, a tenascin-related molecule.
    Schachner M; Taylor J; Bartsch U; Pesheva P
    Perspect Dev Neurobiol; 1994; 2(1):33-41. PubMed ID: 7530142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracellular matrix proteins and VLA integrins expression in the microenvironment of human lung carcinoma.
    Zeromski J; Lawniczak M; Mizera-Nyczak E; Zocchi MR
    Pol J Pathol; 1995; 46(2):63-9. PubMed ID: 7543797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.